Sai Life stock outlook: Given its high-growth outlook and improving profitability, analysts at JM Financial value the stock at 32x Sept 2027 EBITDA to arrive at a target price of ₹1,197.
Mutual Funds increased holding by up to 800 basis points in Clean Science and Technology, Sai Life Sciences and Cohance Lifesciences in September quarter. Here's a technical outlook on these 3 stocks.
At 2:00 PM, Sai Life Sciences shares continued to trade near day's high, up 3.15 per cent higher at ₹922.40 per share. In comparison, BSE Sensex was trading 0.39 per cent lower at 82,693.61 levels.
Sai Life Sciences shares slipped 5 per cent after 1.9 million shares changed hands on BSE, while 37.22 million shares were traded on NSE; here's what analysts suggest
The rally in the share price of Sai Life Sciences comes after the company swung back to report a profit of ₹60 crore in Q1FY26